Daniel Gerber

Cleveland Clinic

Papers

1

Total Citations

14

H-Index

1

About

Dr. Daniel Gerber is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for patients with bladder cancer, particularly through the comparative analysis of open and robotic-assisted radical cystectomy techniques. His most cited work, a 2021 study comparing oncologic outcomes following open and robotic-assisted radical cystectomy with both extracorporeal and intracorporeal urinary diversion, has garnered 14 citations and provides critical insights into the safety and efficacy of minimally invasive approaches. Dr. Gerber’s contributions have helped clarify the role of robotic surgery in complex urologic oncology, addressing key questions about recurrence rates, complication profiles, and functional recovery. His research is instrumental in guiding surgical decision-making and advancing patient-centered care in bladder cancer treatment. Through rigorous comparative effectiveness studies, Dr. Gerber continues to shape evidence-based practices, bridging the gap between traditional open techniques and modern robotic innovations. His work is widely recognized for its practical impact on surgical protocols and its influence on the evolving landscape of urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Oncologic Outcomes Following Open and Robotic-assisted Radical Cystectomy with both Extracorporeal and Intracorporeal Urinary Diversion
14 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Cleveland Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago